NATRUM PHOSPHORICUM (HOMEOLAB USA INC)


Welcome to the PulseAid listing for the NATRUM PHOSPHORICUM drug offered from HOMEOLAB USA INC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: HOMEOLAB USA INC
NON-PROPRIETARY NAME: NATRUM PHOSPHORICUM
SUBSTANCE NAME: SODIUM PHOSPHATE, DIBASIC
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, CHEWABLE
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2014-03-20
END MARKETING DATE: 0000-00-00


NATRUM PHOSPHORICUM HUMAN OTC DRUG Details:

Item DescriptionNATRUM PHOSPHORICUM from HOMEOLAB USA INC
LABELER NAME: HOMEOLAB USA INC
DEA SCHEDULE:
ACTIVE STRENGTH: 6([hp_X]/1)
START MARKETING DATE: 2014-03-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60512-8029_68e922da-3699-4296-aa98-684e70479672
PRODUCT NDC: 60512-8029
APPLICATION NUMBER:

Other SODIUM PHOSPHATE, DIBASIC Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
HOMEOLAB USA INCNATRUM PHOSPHORICUM
HOMEOLAB USA INC.NATRUM PHOSPHORICUM